Keywords: shire, strong, 1st, qtr, wary, over, new
Shire: strong 1st qtr, wary over new drug
Article | 05 May 2008
UK-based drugmaker Shire has announced positive first-quarter 2008 results based on above-market growth of its attention-deficit hyperactivity disorder franchise, yet its ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
